China Natural Resources
CHNR
5 hedge funds and large institutions have $47K invested in China Natural Resources in 2022 Q2 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 3 closing their positions.
0% less ownership
Funds ownership: 0.01% → 0% (-0%)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
38% less funds holding
Funds holding: 8 → 5 (-3)
62% less capital invested
Capital invested by funds: $124K → $47K (-$77K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$802 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$17.2K |
| 2 |
VF
Virtu Financial
New York
|
-$15K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$11K |
| 4 |
Two Sigma Advisers
New York
|
-$10K |
CHNR Hedge Fund Activity: Q2 2022 in Review
5 of the 5,937 institutional investors tracked by Wall St. Rank reported a position in China Natural Resources (CHNR) for Q2 2022, worth a combined $47K — down 62% from $124K a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of CHNR and 0 opened new positions — a net loss of 3 holders — while 1 trimmed existing stakes and 1 added.
The largest buyer was UBS Group, adding an estimated $802. The largest seller was Renaissance Technologies, cutting an estimated $17.2K.
- 5 institutional investors held China Natural Resources (CHNR) as of Q2 2022, down from 8 in Q1 2022.
- Funds reported $47K of China Natural Resources stock for Q2 2022, down 62% quarter-over-quarter.
- 0 funds opened new China Natural Resources positions in Q2 2022 and 3 closed out, a net change of -3 holders.
- The largest China Natural Resources buyer in Q2 2022 was UBS Group, an estimated $802 added.
- The largest China Natural Resources seller in Q2 2022 was Renaissance Technologies, an estimated $17.2K sold.
Based on aggregated 13F filings for Q2 2022.